This is a Validated Antibody Database (VAD) review about cow SRC, based on 44 published articles (read how Labome selects the articles), using SRC antibody in all methods. It is aimed to help Labome visitors find the most suited SRC antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
SRC synonym: proto-oncogene tyrosine-protein kinase Src; v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog; v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog

Cell Signaling Technology
rabbit monoclonal (36D10)
  • western blot; human; loading ...; fig 4d
Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in western blot on human samples (fig 4d). Nat Commun (2018) ncbi
rabbit monoclonal (36D10)
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in western blot on human samples (fig 3a). J Cell Mol Med (2018) ncbi
rabbit monoclonal (36D10)
  • western blot; rat; loading ...; fig 7a
Cell Signaling Technology SRC antibody (Cell Signaling Technology, 2109) was used in western blot on rat samples (fig 7a). Cell Death Dis (2018) ncbi
rabbit monoclonal (36D10)
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in western blot on human samples (fig 3a). Oncogene (2018) ncbi
rabbit monoclonal (36D10)
  • western blot; dog; 1:1000; loading ...; fig 7b
Cell Signaling Technology SRC antibody (Cell Signaling Technology, 2109) was used in western blot on dog samples at 1:1000 (fig 7b). J Cell Sci (2018) ncbi
rabbit monoclonal (36D10)
  • western blot; human; loading ...; fig 4d
Cell Signaling Technology SRC antibody (Cell Signaling Technologies, 2109) was used in western blot on human samples (fig 4d). Oncoimmunology (2017) ncbi
rabbit monoclonal (36D10)
  • western blot; dog; loading ...; fig 3a
Cell Signaling Technology SRC antibody (Cell Signaling Technology, 36D10) was used in western blot on dog samples (fig 3a). Oncogene (2017) ncbi
rabbit monoclonal (36D10)
  • western blot; human; 1:50; loading ...; fig 5b
Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in western blot on human samples at 1:50 (fig 5b). Proc Natl Acad Sci U S A (2017) ncbi
rabbit monoclonal (36D10)
  • western blot; mouse; fig s5c
Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in western blot on mouse samples (fig s5c). J Clin Invest (2017) ncbi
rabbit monoclonal (36D10)
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in western blot on human samples (fig 3c). Cell Rep (2017) ncbi
rabbit monoclonal (36D10)
  • western blot; mouse; loading ...; fig 2c,2g
In order to study the role of CD146 in the formation and retention of macrophage foam cells, Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in western blot on mouse samples (fig 2c,2g). Cell Res (2017) ncbi
rabbit monoclonal (36D10)
  • western blot; human; loading ...; fig s5
Cell Signaling Technology SRC antibody (Cell signaling, 2109S) was used in western blot on human samples (fig s5). Oncotarget (2017) ncbi
rabbit monoclonal (36D10)
  • western blot; mouse; loading ...; fig 5e
In order to propose that casitas B-cell lymphoma family proteins protect mammary epithelial cells from proteotoxic stress-induced cell death by promoting turnover of active c-Src, Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in western blot on mouse samples (fig 5e). Proc Natl Acad Sci U S A (2016) ncbi
rabbit monoclonal (36D10)
  • western blot; human; 1:2000; loading ...; fig 4e
Cell Signaling Technology SRC antibody (cell signalling, 2109) was used in western blot on human samples at 1:2000 (fig 4e). Oncotarget (2017) ncbi
rabbit monoclonal (36D10)
  • western blot; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in western blot on human samples at 1:1000 (fig 4a). Oncol Lett (2016) ncbi
rabbit monoclonal (36D10)
  • western blot; human; loading ...; fig s7
Cell Signaling Technology SRC antibody (cell signalling, 2109) was used in western blot on human samples (fig s7). J Clin Invest (2016) ncbi
rabbit monoclonal (36D10)
  • western blot; human; loading ...; fig 1d
Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in western blot on human samples (fig 1d). J Clin Invest (2016) ncbi
rabbit monoclonal (36D10)
  • western blot; human; 1:1000; loading ...; fig s20a
In order to delineate the mechanism for lung tumorigenesis by a tobacco-specific carcinogen, Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in western blot on human samples at 1:1000 (fig s20a). Nat Commun (2016) ncbi
rabbit monoclonal (36D10)
  • western blot; human; 1:200; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in western blot on human samples at 1:200 (fig st1). Nat Commun (2016) ncbi
rabbit monoclonal (36D10)
  • western blot; human; 1:1000; loading ...; fig 4c
In order to propose that leukemia inhibitory factor signaling confers a dormancy phenotype in breast cancer cells that have disseminated to bone, Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in western blot on human samples at 1:1000 (fig 4c). Nat Cell Biol (2016) ncbi
rabbit monoclonal (36D10)
  • flow cytometry; mouse; loading ...; fig 7c
In order to demonstrate that Siglec-E is required for Escherichia coli-induced endocytosis of TLR4, Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in flow cytometry on mouse samples (fig 7c). J Immunol (2016) ncbi
rabbit monoclonal (36D10)
  • western blot; human; 1:1000; fig 5
Cell Signaling Technology SRC antibody (Cell signaling, 2109S) was used in western blot on human samples at 1:1000 (fig 5). PLoS ONE (2016) ncbi
rabbit monoclonal (36D10)
  • western blot; human; 1:1000; fig 2
In order to compare regulation of a Golgi-activated pool of Src during G2 by centrosomal maturation and Aurora-A recruitment, Cell Signaling Technology SRC antibody (Cell Signaling, 2,109) was used in western blot on human samples at 1:1000 (fig 2). Nat Commun (2016) ncbi
rabbit monoclonal (36D10)
  • western blot; human; loading ...; fig 7
Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in western blot on human samples (fig 7). J Biol Chem (2016) ncbi
rabbit monoclonal (36D10)
  • immunohistochemistry - frozen section; mouse; 1:100; fig 4
  • western blot; mouse; fig 5
Cell Signaling Technology SRC antibody (Cell Signaling Technology, 2109) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 4) and in western blot on mouse samples (fig 5). Nat Commun (2016) ncbi
rabbit monoclonal (36D10)
  • western blot; human; 1:1000; fig 3
In order to determine the different cell signaling pathways between normal and lung cancer-derived exosomes by triple SILAC quantitative proteomic analysis, Cell Signaling Technology SRC antibody (Cell Signaling, 36D10) was used in western blot on human samples at 1:1000 (fig 3). J Proteomics (2016) ncbi
rabbit monoclonal (36D10)
  • immunoprecipitation; human; loading ...; fig 3c
  • western blot; human; loading ...; fig 2a
In order to present the role of CD147 in cancer migration through annexin A2 and DOCK3-catenin-WAVE2 signaling, Cell Signaling Technology SRC antibody (Cell Signaling Technology, 2109) was used in immunoprecipitation on human samples (fig 3c) and in western blot on human samples (fig 2a). Oncotarget (2016) ncbi
rabbit monoclonal (36D10)
  • immunocytochemistry; human; loading ...; fig 1a
In order to present the role of nuclear Src and p300 signaling axis in pancreatic cancer, Cell Signaling Technology SRC antibody (Cell Signaling, 36D10) was used in immunocytochemistry on human samples (fig 1a). Oncotarget (2016) ncbi
rabbit monoclonal (36D10)
  • western blot; human; 1:1000; fig 3
In order to investigate factors that control PHD1 activity, Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in western blot on human samples at 1:1000 (fig 3). J Cell Sci (2016) ncbi
rabbit monoclonal (36D10)
  • western blot; human; fig 7
In order to determine promotion of cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin beta1 and insulin-like growth factor-independent insulin-like growth factor binding protein 3, Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in western blot on human samples (fig 7). Oncotarget (2015) ncbi
rabbit monoclonal (36D10)
  • western blot; human; 1:100; fig s7
In order to analyze organotropic metasistasis and tumour exosome integrins, Cell Signaling Technology SRC antibody (Cell signaling, 2109) was used in western blot on human samples at 1:100 (fig s7). Nature (2015) ncbi
rabbit monoclonal (36D10)
  • immunocytochemistry; human; 2 ug/ml; fig 6
  • western blot; human; 1:1000; fig 6
In order to characterize arterial tortuosity syndrome skin fibroblasts and GLUT10 deficiency leading to non-canonical alpha-gamma-beta3 integrin-mediated TGF-beta singalling and oxidative stress with extracellular matrix disarray, Cell Signaling Technology SRC antibody (Cell Signalling Technology, 36D10) was used in immunocytochemistry on human samples at 2 ug/ml (fig 6) and in western blot on human samples at 1:1000 (fig 6). Hum Mol Genet (2015) ncbi
rabbit monoclonal (36D10)
  • western blot; human; loading ...; fig 8
In order to report the effect of c-Met inhibition using neuroendocrine tumor cells, Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in western blot on human samples (fig 8). Neuroendocrinology (2016) ncbi
rabbit monoclonal (36D10)
  • western blot; mouse; 1:8000
Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in western blot on mouse samples at 1:8000. Neuroscience (2015) ncbi
rabbit monoclonal (36D10)
  • western blot; mouse
In order to assess the role of receptor-interacting protein 2 in VEGF signalling and myocardial ischaemia/reperfusion injury, Cell Signaling Technology SRC antibody (Cell Signalling Technologies, 2109) was used in western blot on mouse samples . Cardiovasc Res (2015) ncbi
rabbit monoclonal (36D10)
In order to study mechanisms that confer resistance to therapeutic interventions in the insulin-like growth factor receptor pathway, Cell Signaling Technology SRC antibody (CST, 2109) was used . Mol Cancer (2015) ncbi
rabbit monoclonal (36D10)
  • western blot; human; fig s1
Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in western blot on human samples (fig s1). Cell Death Dis (2015) ncbi
rabbit monoclonal (36D10)
  • western blot; human
Cell Signaling Technology SRC antibody (Cell Signaling Technology, 36D10) was used in western blot on human samples . Oncogene (2015) ncbi
rabbit monoclonal (36D10)
  • immunocytochemistry; human; fig 2
Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in immunocytochemistry on human samples (fig 2). Cancer Lett (2015) ncbi
rabbit monoclonal (36D10)
  • western blot; human; fig 2
Cell Signaling Technology SRC antibody (Cell Signaling Technology, 2109) was used in western blot on human samples (fig 2). Oncotarget (2015) ncbi
rabbit monoclonal (36D10)
  • western blot; human
In order to identify mechanisms by which metastatic gastroesophageal adenocarcinomas develop resistance to ERBB2 inhibition, Cell Signaling Technology SRC antibody (Cell Signaling Technologies, 2109) was used in western blot on human samples . PLoS ONE (2014) ncbi
rabbit monoclonal (36D10)
  • immunocytochemistry; human
  • immunohistochemistry; human
Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in immunocytochemistry on human samples and in immunohistochemistry on human samples . Breast Cancer Res (2014) ncbi
rabbit monoclonal (36D10)
  • western blot; human
Cell Signaling Technology SRC antibody (Cell Signaling, 2109) was used in western blot on human samples . Cell Death Dis (2014) ncbi
rabbit monoclonal (36D10)
  • western blot; human
  • immunohistochemistry - paraffin section; mouse
In order to describe the physiological role of AFAP1 in lactation, Cell Signaling Technology SRC antibody (Cell Signaling, 36D10) was used in western blot on human samples and in immunohistochemistry - paraffin section on mouse samples . Oncogene (2015) ncbi
Articles Reviewed
  1. Pircher J, Czermak T, Ehrlich A, Eberle C, Gaitzsch E, Margraf A, et al. Cathelicidins prime platelets to mediate arterial thrombosis and tissue inflammation. Nat Commun. 2018;9:1523 pubmed publisher
  2. Vl kov K, Vachtenheim J, R da J, Hor k P, Ondru ov L. Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells. J Cell Mol Med. 2018;22:2240-2251 pubmed publisher
  3. De Pasquale V, Pezone A, Sarogni P, Tramontano A, Schiattarella G, Avvedimento V, et al. EGFR activation triggers cellular hypertrophy and lysosomal disease in NAGLU-depleted cardiomyoblasts, mimicking the hallmarks of mucopolysaccharidosis IIIB. Cell Death Dis. 2018;9:40 pubmed publisher
  4. Han B, Zhou B, Qu Y, Gao B, Xu Y, Chung S, et al. FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer. Oncogene. 2018;37:1399-1408 pubmed publisher
  5. Van Itallie C, Tietgens A, Aponte A, Gucek M, Cartagena Rivera A, Chadwick R, et al. MARCKS-related protein regulates cytoskeletal organization at cell-cell and cell-substrate contacts in epithelial cells. J Cell Sci. 2018;131: pubmed publisher
  6. Penafuerte C, Feldhammer M, Mills J, Vinette V, Pike K, Hall A, et al. Downregulation of PTP1B and TC-PTP phosphatases potentiate dendritic cell-based immunotherapy through IL-12/IFN? signaling. Oncoimmunology. 2017;6:e1321185 pubmed publisher
  7. Zhang K, Myllymäki S, Gao P, Devarajan R, Kytölä V, Nykter M, et al. Oncogenic K-Ras upregulates ITGA6 expression via FOSL1 to induce anoikis resistance and synergizes with αV-Class integrins to promote EMT. Oncogene. 2017;36:5681-5694 pubmed publisher
  8. Heim J, Squirewell E, Neu A, Zocher G, Sominidi Damodaran S, Wyles S, et al. Myosin-1E interacts with FAK proline-rich region 1 to induce fibronectin-type matrix. Proc Natl Acad Sci U S A. 2017;114:3933-3938 pubmed publisher
  9. Matsumoto Y, LaRose J, Kent O, Lim M, Changoor A, Zhang L, et al. RANKL coordinates multiple osteoclastogenic pathways by regulating expression of ubiquitin ligase RNF146. J Clin Invest. 2017;127:1303-1315 pubmed publisher
  10. Gonzalez M, Martin E, Anwar T, Arellano Garcia C, Medhora N, Lama A, et al. Mesenchymal Stem Cell-Induced DDR2 Mediates Stromal-Breast Cancer Interactions and Metastasis Growth. Cell Rep. 2017;18:1215-1228 pubmed publisher
  11. Luo Y, Duan H, Qian Y, Feng L, Wu Z, Wang F, et al. Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis. Cell Res. 2017;27:352-372 pubmed publisher
  12. Kozlova N, Wottawa M, Katschinski D, Kristiansen G, Kietzmann T. Hypoxia-inducible factor prolyl hydroxylase 2 (PHD2) is a direct regulator of epidermal growth factor receptor (EGFR) signaling in breast cancer. Oncotarget. 2017;8:9885-9898 pubmed publisher
  13. Mukhopadhyay C, Triplett A, Bargar T, HECKMAN C, Wagner K, Naramura M. Casitas B-cell lymphoma (Cbl) proteins protect mammary epithelial cells from proteotoxicity of active c-Src accumulation. Proc Natl Acad Sci U S A. 2016;113:E8228-E8237 pubmed publisher
  14. Bonan S, Albrengues J, Grasset E, Kuzet S, Nottet N, Bourget I, et al. Membrane-bound ICAM-1 contributes to the onset of proinvasive tumor stroma by controlling acto-myosin contractility in carcinoma-associated fibroblasts. Oncotarget. 2017;8:1304-1320 pubmed publisher
  15. Ji H, Li B, Zhang S, He Z, Zhou Y, Ouyang L. Crk-like adapter protein is overexpressed in cervical carcinoma, facilitates proliferation, invasion and chemoresistance, and regulates Src and Akt signaling. Oncol Lett. 2016;12:3811-3817 pubmed
  16. Matsumoto Y, La Rose J, Kent O, Wagner M, Narimatsu M, Levy A, et al. Reciprocal stabilization of ABL and TAZ regulates osteoblastogenesis through transcription factor RUNX2. J Clin Invest. 2016;126:4482-4496 pubmed publisher
  17. Wang S, Chennupati R, Kaur H, Iring A, Wettschureck N, Offermanns S. Endothelial cation channel PIEZO1 controls blood pressure by mediating flow-induced ATP release. J Clin Invest. 2016;126:4527-4536 pubmed publisher
  18. Boo H, Min H, Jang H, Yun H, Smith J, Jin Q, et al. The tobacco-specific carcinogen-operated calcium channel promotes lung tumorigenesis via IGF2 exocytosis in lung epithelial cells. Nat Commun. 2016;7:12961 pubmed publisher
  19. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
  20. Johnson R, Finger E, Olcina M, Vilalta M, Aguilera T, Miao Y, et al. Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow. Nat Cell Biol. 2016;18:1078-1089 pubmed publisher
  21. Wu Y, Ren D, Chen G. Siglec-E Negatively Regulates the Activation of TLR4 by Controlling Its Endocytosis. J Immunol. 2016;197:3336-3347 pubmed
  22. Liu M, Feng L, Sun P, Liu W, Wu W, Jiang B, et al. A Novel Bufalin Derivative Exhibited Stronger Apoptosis-Inducing Effect than Bufalin in A549 Lung Cancer Cells and Lower Acute Toxicity in Mice. PLoS ONE. 2016;11:e0159789 pubmed publisher
  23. Barretta M, Spano D, D Ambrosio C, Cervigni R, Scaloni A, Corda D, et al. Aurora-A recruitment and centrosomal maturation are regulated by a Golgi-activated pool of Src during G2. Nat Commun. 2016;7:11727 pubmed publisher
  24. Rorsman C, Tsioumpekou M, Heldin C, Lennartsson J. The Ubiquitin Ligases c-Cbl and Cbl-b Negatively Regulate Platelet-derived Growth Factor (PDGF) BB-induced Chemotaxis by Affecting PDGF Receptor β (PDGFRβ) Internalization and Signaling. J Biol Chem. 2016;291:11608-18 pubmed publisher
  25. Roy J, Kim B, Hill E, Visconti P, Krapf D, Vinegoni C, et al. Tyrosine kinase-mediated axial motility of basal cells revealed by intravital imaging. Nat Commun. 2016;7:10666 pubmed publisher
  26. Clark D, Fondrie W, Yang A, Mao L. Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes. J Proteomics. 2016;133:161-169 pubmed publisher
  27. Cui H, Wang S, Miao J, Fu Z, Feng F, Wu J, et al. CD147 regulates cancer migration via direct interaction with Annexin A2 and DOCK3-β-catenin-WAVE2 signaling. Oncotarget. 2016;7:5613-29 pubmed publisher
  28. Paladino D, Yue P, Furuya H, Acoba J, Rosser C, Turkson J. A novel nuclear Src and p300 signaling axis controls migratory and invasive behavior in pancreatic cancer. Oncotarget. 2016;7:7253-67 pubmed publisher
  29. Ortmann B, Bensaddek D, Carvalhal S, Moser S, Mudie S, Griffis E, et al. CDK-dependent phosphorylation of PHD1 on serine 130 alters its substrate preference in cells. J Cell Sci. 2016;129:191-205 pubmed publisher
  30. Yen Y, Hsiao J, Jiang S, Chang J, Wang S, Shen Y, et al. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1. Oncotarget. 2015;6:41837-55 pubmed publisher
  31. Hoshino A, Costa Silva B, Shen T, Rodrigues G, Hashimoto A, Tesic Mark M, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527:329-35 pubmed publisher
  32. Zoppi N, Chiarelli N, Cinquina V, Ritelli M, Colombi M. GLUT10 deficiency leads to oxidative stress and non-canonical αvβ3 integrin-mediated TGFβ signalling associated with extracellular matrix disarray in arterial tortuosity syndrome skin fibroblasts. Hum Mol Genet. 2015;24:6769-87 pubmed publisher
  33. Reuther C, Heinzle V, Spampatti M, Vlotides G, de Toni E, Spöttl G, et al. Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition. Neuroendocrinology. 2016;103:383-401 pubmed publisher
  34. Tang Y, Ye M, Du Y, Qiu X, Lv X, Yang W, et al. EGFR signaling upregulates surface expression of the GluN2B-containing NMDA receptor and contributes to long-term potentiation in the hippocampus. Neuroscience. 2015;304:109-21 pubmed publisher
  35. Andersson L, Scharin Täng M, Lundqvist A, Lindbom M, Mardani I, Fogelstrand P, et al. Rip2 modifies VEGF-induced signalling and vascular permeability in myocardial ischaemia. Cardiovasc Res. 2015;107:478-86 pubmed publisher
  36. Min H, Yun H, Lee J, Lee H, Cho J, Jang H, et al. Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer. Mol Cancer. 2015;14:113 pubmed publisher
  37. Cheng H, Liang Y, Kuo Y, Chuu C, Lin C, Lee M, et al. Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data. Cell Death Dis. 2015;6:e1753 pubmed publisher
  38. Spring K, Fournier P, Lapointe L, Chabot C, Roussy J, Pommey S, et al. The protein tyrosine phosphatase DEP-1/PTPRJ promotes breast cancer cell invasion and metastasis. Oncogene. 2015;34:5536-47 pubmed publisher
  39. Ward J, Ha J, Jayaraman M, Dhanasekaran D. LPA-mediated migration of ovarian cancer cells involves translocalization of Gαi2 to invadopodia and association with Src and β-pix. Cancer Lett. 2015;356:382-91 pubmed publisher
  40. Wang S, Cui H, Liu Y, Zhao P, Zhang Y, Fu Z, et al. CD147 promotes Src-dependent activation of Rac1 signaling through STAT3/DOCK8 during the motility of hepatocellular carcinoma cells. Oncotarget. 2015;6:243-57 pubmed
  41. Hong Y, Kim J, Pectasides E, Fox C, Hong S, Ma Q, et al. Src mutation induces acquired lapatinib resistance in ERBB2-amplified human gastroesophageal adenocarcinoma models. PLoS ONE. 2014;9:e109440 pubmed publisher
  42. Ghaffari A, Hoskin V, Szeto A, Hum M, Liaghati N, Nakatsu K, et al. A novel role for ezrin in breast cancer angio/lymphangiogenesis. Breast Cancer Res. 2014;16:438 pubmed publisher
  43. Guo W, Liu R, Bhardwaj G, Yang J, Changou C, Ma A, et al. Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor. Cell Death Dis. 2014;5:e1409 pubmed publisher
  44. Cunnick J, Kim S, Hadsell J, Collins S, Cerra C, Reiser P, et al. Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland. Oncogene. 2015;34:2640-9 pubmed publisher